Abstract
A series of ethyl 2-amino-4H-benzo[h]chromene-3-carboxylate derivatives, having phenyl ring with diverse substituents at C4 position of 4H-benzochromene nucleus, were synthesized via one-pot three-component reaction between various aromatic aldehydes, α-naphthol, and ethyl cyanoacetate. The synthesized compounds were screened for their antityrosinase activity. Compound 4i, bearing 4-dimethylamino substitution on C4-phenyl ring, was the most potent tyrosinase inhibitor (IC50 = 34.12 μM). The inhibition kinetic analysis of 4i indicated that the compound was a competitive tyrosinase inhibitor. Compounds 4a, 4g, 4i and 4j were the effective radical scavengers with EC50s in the range of 0.144–0.943 mM. According to the in silico drug-like and ADME predictions, 4i can be considered as a suitable candidate. Molecular docking results confirmed that the derivative was well accommodated within the mushroom tyrosinase binding site. Therefore, 4i can be introduced as a novel tyrosinase inhibitor that might be a promising lead in medicine, cosmetics, and food industry.
Graphic abstract
Similar content being viewed by others
References
Seo S-Y, Sharma VK, Sharma N (2003) Mushroom tyrosinase: recent prospects. J Agric Food Chem 51:2837–2853
Casanola-Martin GM, Le-Thi-Thu H, Marrero-Ponce Y, Castillo-Garit JA, Torrens F et al (2014) Tyrosinase enzyme: 1. An overview on a pharmacological target. Curr Top Med Chem 14:1494–1501
Masum MN, Yamauchi K, Mitsunaga T (2019) Tyrosinase inhibitors from natural and synthetic sources as skin-lightening agents. Rev Agric Sci 7:41–58
Greggio E, Bergantino E, Carter D, Ahmad R, Costin GE et al (2005) Tyrosinase exacerbates dopamine toxicity but is not genetically associated with Parkinson’s disease. J Neurochem 93:246–256
Carballo-Carbajal I, Laguna A, Romero-Giménez J, Cuadros T, Bové J et al (2019) Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson’s disease pathogenesis. Nat Commun 10:973
Lee SY, Baek N, Nam T-g (2016) Natural, semisynthetic and synthetic tyrosinase inhibitors. J Enzyme Inhib Med Chem 31:1–13
Chiari ME, Vera DMA, Palacios SM, Carpinella MC (2011) Tyrosinase inhibitory activity of a 6-isoprenoid-substituted flavanone isolated from Dalea elegans. Bioorg Med Chem 19:3474–3482
Karioti A, Protopappa A, Megoulas N, Skaltsa H (2007) Identification of tyrosinase inhibitors from Marrubium velutinum and Marrubium cylleneum. Bioorg Med Chem 15:2708–2714
Zolghadri S, Bahrami A, Hassan Khan MT, Munoz-Munoz J, Garcia-Molina F et al (2019) A comprehensive review on tyrosinase inhibitors. J Enzyme Inhib Med Chem 34:279–309
Ellis GP (2009) Chromenes, chromanones, and chromones. Wiley, Hoboken
Pratap R, Ram VJ (2014) Natural and synthetic chromenes, fused chromenes, and versatility of dihydrobenzo[h]chromenes in organic synthesis. Chem Rev 114:10476–10526
Sharma K, Kumar S, Chand K, Kathuria A, Gupta A et al (2011) An update on natural occurrence and biological activity of chromones. Curr Med Chem 18:3825–3852
Emami S, Ghanbarimasir Z (2015) Recent advances of chroman-4-one derivatives: synthetic approaches and bioactivities. Eur J Med Chem 93:539–563
Keri RS, Budagumpi S, Pai RK, Balakrishna RG (2014) Chromones as a privileged scaffold in drug discovery: a review. Eur J Med Chem 78:340–374
Patil SA, Patil R, Pfeffer LM, Miller DD (2013) Chromenes: potential new chemotherapeutic agents for cancer. Future Med Chem 5:1647–1660
Abu-Hashem AA, El-Shazly M (2015) Synthesis, reactions and biological activities of furochromones: a review. Eur J Med Chem 90:633–665
Ramdani LH, Talhi O, Decombat C, Vermerie M, Berry A et al (2019) Bis (4-hydroxy-2H-chromen-2-one) coumarin induces apoptosis in MCF-7 human breast cancer cells through aromatase inhibition. Anticancer Res 39:6107–6114
Alblewi FF, Okasha RM, Hritani ZM, Mohamed HM, El-Nassag MA et al (2019) Antiproliferative effect, cell cycle arrest and apoptosis generation of novel synthesized anticancer heterocyclic derivatives based 4H-benzo[h]chromene. Bioorg Chem 87:560–571
Morimura K, Yamazaki C, Hattori Y, Makabe H, Kamo T et al (2007) A tyrosinase inhibitor, Daedalin A, from mycelial culture of Daedalea dickinsii. Biosci Biotechnol Biochem 71:70266-1–70266-4
Hu X, Wu J-W, Wang M, Yu M-H, Zhao Q-S et al (2011) 2-Arylbenzofuran, flavonoid, and tyrosinase inhibitory constituents of Morus yunnanensis. J Nat Prod 75:82–87
Peralta MA, Ortega MG, Agnese AM, Cabrera JL (2011) Prenylated flavanones with anti-tyrosinase activity from Dalea boliviana. J Nat Prod 74:158–162
Şöhretoğlu D, Sari S, Barut B, Özel A (2018) Tyrosinase inhibition by some flavonoids: inhibitory activity, mechanism by in vitro and in silico studies. Bioorg Chem 81:168–174
Lee NK, Son KH, Chang HW, Kang SS, Park H et al (2004) Prenylated flavonoids as tyrosinase inhibitors. Arch Pharm Res 27:1132–1135
Kim SJ, Son KH, Chang HW, Kang SS, Kim HP (2003) Tyrosinase inhibitory prenylated flavonoids from Sophora flavescens. Biol Pharm Bull 26:1348–1350
Kishore N, Twilley D, Blom van Staden A, Verma P, Singh B et al (2018) Isolation of flavonoids and flavonoid glycosides from Myrsine africana and their inhibitory activities against mushroom tyrosinase. J Nat Prod 81:49–56
Yu L (2003) Inhibitory effects of (S)-and (R)-6-hydroxy-2, 5, 7, 8-tetramethylchroman-2-carboxylic acids on tyrosinase activity. J Agric Food Chem 51:2344–2347
Sabitha G, Bhikshapathi M, Nayak S, Srinivas R, Yadav J (2011) Triton B catalyzed three-component, one-pot synthesis of 2-amino-2-chromenes at ambient temperature. J Heterocycl Chem 48:267–271
Khurana JM, Nand B, Saluja P (2010) DBU: a highly efficient catalyst for one-pot synthesis of substituted 3, 4-dihydropyrano [3, 2-c] chromenes, dihydropyrano [4, 3-b] pyranes, 2-amino-4H-benzo[h]chromenes and 2-amino-4H benzo[g]chromenes in aqueous medium. Tetrahedron 66:5637–5641
Chaker A, Najahi E, Nepveu F, Chanchoub F (2017) Microwave-assisted synthesis of chromeno [2, 3-d] pyrimidinone derivatives. Arab J Chem 10:S3040–S3047
Ha Young Mi, Chung Sang Woon, Song Suhee, Lee Hyojin, Suh Hongsuk et al (2007) 4-(6-Hydroxy-2-naphthyl)-1,3-bezendiol: a potent, new tyrosinase inhibitor. Biol Pharm Bull 30:1711–1715
Ranjbar S, Akbari A, Edraki N, Khoshneviszadeh M, Hemmatian H et al (2018) 6-Methoxy-3, 4-dihydronaphthalenone chalcone-like derivatives as potent tyrosinase inhibitors and radical scavengers. Lett Drug Des Discov 15:1170–1179
Tehrani MB, Emani P, Rezaei Z, Khoshneviszadeh M, Ebrahimi M et al (2019) Phthalimide-1, 2, 3-triazole hybrid compounds as tyrosinase inhibitors; synthesis, biological evaluation and molecular docking analysis. J Mol Struct 1176:86–93
Dehghani Z, Khoshneviszadeh M, Khoshneviszadeh M, Ranjbar S (2019) Veratric acid derivatives containing benzylidene-hydrazine moieties as promising tyrosinase inhibitors and free radical scavengers. Bioorg Med Chem 27:2644–2645
Mahdavi M, Ashtari A, Khoshneviszadeh M, Ranjbar S, Dehghani A et al (2018) Synthesis of new benzimidazole-1, 2, 3-triazole hybrids as tyrosinase inhibitors. Chem Biodivers 15:e1800120
Ghafari S, Ranjbar S, Larijani B, Amini M, Biglar M et al (2019) Novel morpholine containing cinnamoyl amides as potent tyrosinase inhibitors. Int J Biol Macromol 135:978–985
Acknowledgements
This work was supported by Vice-Chancellor for Research, Shiraz University of Medical Sciences with Grant No. 95-01-103-12178. The authors wish to thank Mr. H. Argasi at the Research Consultation Center (RCC) of Shiraz University of Medical Sciences for his invaluable assistance in editing this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Karimian, S., Ranjbar, S., Dadfar, M. et al. 4H-benzochromene derivatives as novel tyrosinase inhibitors and radical scavengers: synthesis, biological evaluation, and molecular docking analysis. Mol Divers 25, 2339–2349 (2021). https://doi.org/10.1007/s11030-020-10123-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11030-020-10123-0